Syros Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q2 2024.
  • Syros Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$27.4M, a 19.4% increase year-over-year.
  • Syros Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$120M, a 15.8% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$129M, a 5.07% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$136M, a 36.7% decline from 2021.
  • Syros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$99.4M, a 20.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$120M -$27.4M +$6.58M +19.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 -$127M -$30.9M +$2.29M +6.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$129M -$27.1M +$8.86M +24.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$138M -$34.6M +$4.82M +12.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$143M -$34M -$231K -0.68% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 -$142M -$33.2M -$6.56M -24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$136M -$36M -$10.6M -41.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$125M -$39.5M -$12.5M -46.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$113M -$33.8M -$7.63M -29.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$105M -$26.7M -$5.71M -27.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$99.4M -$25.4M +$3.8M +13% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$103M -$26.9M -$7.91M -41.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$95.3M -$26.1M -$9.4M -56.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$85.9M -$20.9M -$3.6M -20.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$82.3M -$29.2M -$9.05M -44.9% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-04
Q3 2020 -$73.2M -$19M +$1.39M +6.83% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$74.6M -$16.7M +$3.47M +17.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$78.1M -$17.3M -$366K -2.16% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$77.7M -$20.2M -$1.56M -8.41% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$76.2M -$20.4M -$4.07M -24.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-04
Q2 2019 -$72.1M -$20.2M -$5.66M -38.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-04
Q1 2019 -$66.4M -$17M -$2.15M -14.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-04
Q4 2018 -$64.3M -$18.6M -$3.09M -19.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$61.2M -$16.3M -$2.28M -16.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 -$58.9M -$14.5M -$1.04M -7.66% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 -$57.9M -$14.8M -$3.21M -27.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 -$54.7M -$15.5M -$4.48M -40.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$50.2M -$14M +$177K +1.25% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$50.4M -$13.5M -$1.45M -12% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$48.9M -$11.6M -$977K -9.19% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$48M -$11M -$356K -3.33% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$47.6M -$14.2M -$5.75M -68% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$41.9M -$12.1M -$5.97M -97.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$35.9M -$10.6M -$6.06M -133% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$29.8M -$10.7M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-20
Q3 2015 -$8.46M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-20
Q2 2015 -$6.1M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-20
Q1 2015 -$4.57M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.